SYBX - CONSENSUS CO - Synlogic, Inc.

The daily price chart for Synlogic, Inc. (SYBX) on the GURU.Markets platform demonstrates the asset's decline, as it has effectively lost its chances for success due to the suspension of critical research and is now seeking a buyer. Previously, the business relied on expansion into metabolic therapies via Synthetic Biotics, aiming to capture untapped niches. The company's innovations were based on microbiome programming using modified bacteria, which currently constitutes .

For Synlogic, Inc. (SYBX), which develops innovative "living" medicines through synthetic biology experts, this indicator reflects the arithmetic mean of target prices provided by sector analysts. By analyzing the median analyst price forecast, an investor assesses the fundamental gap between the current price and fair value, which helps determine growth potential or identify vulnerabilities in the company's business model.